- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/23 - Calcitonins
Patent holdings for IPC class A61K 38/23
Total number of patents in this class: 160
10-year publication summary
|
7
|
10
|
11
|
13
|
6
|
4
|
10
|
11
|
12
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| MannKind Corporation | 529 |
8 |
| Enteris Biopharma, Inc. | 22 |
5 |
| Keybioscience AG | 14 |
5 |
| Camurus AB | 148 |
4 |
| Mondobiotech Laboratories AG | 311 |
4 |
| Shin Nippon Biomedical Laboratories, Ltd. | 86 |
4 |
| The Governors of the University of Alberta | 873 |
3 |
| Regeneron Pharmaceuticals, Inc. | 4643 |
3 |
| SDG, Inc. | 29 |
3 |
| Tokyo Institute of Technology | 1322 |
3 |
| The Royal Institution for The Advancement of Learning / McGill University | 713 |
3 |
| Kindeva Drug Delivery L.P., Kindeva GP II LLC, a Delaware limited liability company | 214 |
3 |
| Nepsone ehf | 4 |
3 |
| Park Therapeutics, Inc. | 5 |
3 |
| The Regents of the University of California | 20590 |
2 |
| Merck Patent GmbH | 5669 |
2 |
| Massachusetts Institute of Technology | 10204 |
2 |
| The General Hospital Corporation | 4840 |
2 |
| Asahi Kasei Pharma Corporation | 116 |
2 |
| The Broad Institute, Inc. | 1948 |
2 |
| Other owners | 94 |